Upregulation of activin A gene by butyrate in human colon cancer cell lines

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 284, Issue 6 47-6, 2003, Pages

  Sonoyama, Kei ^a   Pholnukulkit, Pimara ^a   Toyoda, Masahiko ^a   Rutatip, Suriya ^a   Kasai, Takanori ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cancer; Dietary fiber; Transforming growth factor

Indexed keywords

ACTIVIN A; BUTYRIC ACID; GENOMIC DNA; TUMOR PROMOTER;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL STRAIN CACO 2; CELL STRAIN HT29; COLORECTAL CANCER; CONTROLLED STUDY; DIETARY FIBER; FERMENTATION; FLOW CYTOMETRY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0038586231     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00384.2002     Document Type: Article

References (36)

1. Bernard JA and Warwick G. Butyrate rapidly induces growth inhibition and differentiation in HT29 cells. Cell Growth Differ 4: 495-501, 1993.
2. Bruce WR. Recent hypotheses for the origin of colon cancer. Cancer Res 47: 4237-4242, 1987.
3. Burkitt DP. Relationship as a clue to causation. Lancet 2: 1237-1240, 1970.
4. Chung YS, Song IS, Erickson RH, Sleisenger MH, and Kim YS. Effect of growth and sodium butyrate on brush border membrane-associated hydrolases in human colorectal cancer cell lines. Cancer Res 45: 2976-2982, 1985.
5. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL, and Attisano L. MADR2 maps to 18q21 and encodes a TGF-beta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86: 543-552, 1996.
6. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 6: 164-179, 1995.
7. Goldin BR and Gorbach SL. The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer. J Natl Cancer Inst 57: 371-375, 1976.
8. Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D, and Paraskeva C. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway-implications for the possible role of dietary fibre in the prevention of large bowel cancer. Int J Cancer 55: 498-505, 1993.
9. Hauri HP, Sterchi EE, Bienz D, Fransen JAM, and Marxer A. Expression and intracellular transport of microvillus membrane hydrolases in human intestinal epithelial cells. J Cell Biol 101: 838-851, 1985.
10. Hubner G, Alzheimer C, and Werner S. Activin: a novel player in tissue repair processes. Histol Histopathol 14: 295-304, 1999.
11. Kim YI. AGA technical review: impact of dietary fiber on colon cancer occurrence. Gastroenterology 118: 1235-1257, 2000.
12. Kim YS, Tsao D, Siddiqui B, Whitehead JS, Arnstein P, Bennett J, and Hicks J. Effects of sodium butyrate and dimethylsulfoxide on biochemical properties of human colon cancer cells. Cancer 45: 1185-1192, 1980.
13. Kingsley DM. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8: 133-146, 1994.
14. Kruh J, Tichonicky L, and Defer N. Effect of butyrate on gene expression. In: Short Chain Fatty Acids, edited by Binder HJ, Cummings JH, and Soergel K. Dordrecht, The Netherlands: Kluwer, 1994.
15. Ling N, Ying SA, Ueno N, Shimasaki S, Esch F, Hotta M, and Guillemin R. Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin. Nature 321: 779-782, 1986.
16. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, and Willson JKV. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338, 1995.
17. Massagué J. The transforming growth factor-β family. Annu Rev Cell Biol 6: 597-641, 1990.
18. Mathews LS and Vale WW. Molecular and functional characterization of activin receptors. Receptor 3: 173-181, 1993.
19. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 3: 687-695, 1994.
20. Michel U, Farnworth P, and Findlay JK. Follistatins: more than follicle-stimulating hormone suppressing proteins. Mol Cell Endocrinol 91: 1-11, 1993.
21. Mortensen PB and Clausen MR. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol 216: 132-148, 1996.
22. Munz B, Smola H, Engelhardt F, Bleuel K, Brauchle M, Lein I, Evans LW, Huylebroeck D, Balling R, and Werner S. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO J 18: 5205-5215, 1999.
23. Reddy BS, Sharma C, Simi B, Engle A, Laakso K, Puska P, and Korpela R. Metabolic epidemiology of colon cancer: effect of dietary fiber on fecal mutagens and bile acids in healthy subjects. Cancer Res 47: 644-648, 1987.
24. Reeves PG, Nielsen FH, and Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123: 1939-1951, 1993.
25. Roberton AM, Ferguson LR, Hollands HJ, and Harris PJ. Adsorption of a hydrophobic mutagen to five contrasting dietary fiber preparations. Mutat Res 262: 195-202, 1991.
26. Scheppach W, Bartram HP, and Richter F. Role of short-chain fatty acids in the prevention of colorectal cancer. Eur J Cancer 31A: 1077-1080, 1995.
27. Smith-Barbaro PD, Hanse D, and Reddy BS. Carcinogen binding to various types of dietary fiber. J Natl Cancer Inst 67: 495-497, 1981.
28. Sonoyama K, Rutatip S, and Kasai T. Gene expression of activin, activin receptors, and follistatin in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 278: G89-G97, 2000.
29. Story JA and Kirtchevsky D. Comparison of the binding of various bile acids and bile salts in vitro by several types of fiber. J Nutr 106: 1292-1294, 1976.
30. Takagi Y, Kohmura H, Futamura M, Kida H, Tanemura H, Shimokawa K, and Saji S. Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology 111: 1369-1372, 1996.
31. Toscani A, Soprano DR, and Soprano KJ. Molecular analysis of sodium butyrate-induced growth arrest. Oncogene Res 3: 223-228, 1988.
32. Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, Karr D, and Spiess J. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321: 776-779, 1986.
33. Wankell M, Munz B, Hubner G, Hans W, Wolf E, Goppelt A, and Werner S. Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis. EMBO J 20: 5361-5372, 2001.
34. Whitlock JP, Galeazzi D, and Schulman H. Acetylation and calcium dependent phosphorylation of histone H3 in nuclei from butyrate-treated HeLa cells. J Biol Chem 258: 1299-1304, 1983.
35. Wildi S, Kleeff J, Maruyama H, Maurer CA, Buchler MW, and Korc M. Overexpression of activin A in stage IV colorectal cancer. Gut 49: 409-417, 2001.
36. Zhu Y, Richardson JA, Parada LF, and Graff JM. Smad3 mutant mice develop metastatic colorectal cancer. Cell 94: 703-714, 1998.